현대사료

016790KOSDAQ동물용 사료 및 조제식품 제조업

37.0 / 100

Reference Date: 2026-04-13

Financial Score12.0 / 40

News Sentiment5.0 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is low with sound financial health but PER raises overvaluation concerns. Roughly flat over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hyundai Sahyo expanded its biotechnology business by acquiring LS L&C in 2023, focusing on developing the ovarian cancer treatment candidate 'Oregovomab'. The company emphasizes immunotherapy research amid the pharmaceutical industry's high entry barriers and growth potential, temporarily pausing its metastatic breast cancer pipeline. It concurrently operates a feed business alongside its biotech initiatives.

Number of Employees

68people

Average Salary

56.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

43.22Industry Average 11.220.0Point

3.9x industry avg (risky)

PBR

2.45Industry Average 0.770.0Point

3.2x industry avg (risky)

ROE

5.30Industry Average 6.302.5Point

Below industry avg

Debt Ratio

11.45Industry Average 11.594.0Point

In line with industry avg

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼16.0% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲107.8% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 555.8% (declining, 2yr)

Detailed News Sentiment

1 totalPositive 0Neutral 0Negative 1Average Sentiment Score 20

Negative
현대사료, 공개매각 2차 입찰도 유찰… 최대주주 주식 압류 해소 국면....
현대사료가 경영권 매각 2차 입찰에서도 매수자를 찾지 못했으며, 최대주주의 주식 압류 문제와 상장폐지 가능성이 부각되고 있습니다.

Detailed Momentum

52-week position4.0Point

52w mid range (50%)

Current 994Won52-week high 99452-week low 994

1-month return3.0Point

1m 0% (flat)

Volume trend3.0Point

Volume flat

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0

Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
Neutral정기주주총회결과2026-03-31
Neutral사업보고서 (2025.12)2026-03-24
Neutral[기재정정]투자판단관련주요경영사항 (주식압류해제)2026-03-24
Neutral감사보고서제출2026-03-23